Identify and distinguish among disorders of language function and neurologically recognized aphasic syndromes with the BDAE 3.
The BDAE 3 is designed to highlight the features of patients' performance that are
characteristics of the particular aphasic deficits. It helps you distinguish among
neurologically recognized aphasic syndromes.
- Conversational and Expository Speech
- Auditory Comprehension
- Oral Expression (now including the Boston Naming Test)
- Apraxia Assessment
- Boston Naming Test-Third Edition
- Supplementary Nonlanguage Tests
- Long Form: dependent on how many tests the examiner chooses to administer
- Short Form: 30-45 minutes
- Severity Rating
- Profile of Speech Characteristics
This is an inventory of tests the examiner can choose to administer at will. The long form includes items from every test in the inventory. The short form uses selected items from each of the tests and is designed for the examiner who has limited time (40-60 minutes) to spend with a patient. The examiner should be familiar with the Extended Testing options which more thoroughly probe particular language functions within each area of testing. The text, The Assessment of Aphasia and Related Disorders is included with the test set and offers complete coverage of:
- the nature of aphasia, its definition, and characteristics
- the normative basis for the BDAE scoring system
- specific explanation of how to administer the exam
- how to interpret the Test Score profiles and recognize aphasic syndromes and their origins
- a severity rating scale that measures your client's communicative ability
- testing of visuospatial and quantitative skills after brain injury
This test may be administered and interpreted by licensed and certified speech-language pathologists familiar with aphasia.
Copyright © 2001